Archives
ASA: Embolization of MMA Cuts Risk for Subsequent Subdural Hematoma, Surgery
Complications related to the embolization procedure low, and neurological function comparable with, without embolization
Use of Transcatheter Aortic Valve Replacement Up in Adults Younger Than 60
Five-year survival significantly better after surgical aortic valve replacement; no difference seen in secondary outcomes versus TAVR
Pembrolizumab Improves Event-Free Survival in Early NSCLC
For resectable early-stage NSCLC, improved event-free survival seen with pembrolizumab, regardless of N status, clinical stage, type of surgery
Fruquintinib + Paclitaxel Aids Advanced Gastric/Gastroesophageal Junction Cancer
Improvement seen in progression-free survival among patients who had disease progression on first-line chemotherapy
ASA: Stroke Survivors Face Twofold Higher Risk for MI One Year After Stroke
Findings seen with or without cervical artery dissection
ASA: Nearly One in Five People Develop Dementia After Stroke
In the first year after stroke, there is an almost threefold higher risk for dementia
ASA: Vagus Nerve Stimulation + Rehab Boosts Arm, Hand Function in Stroke Survivors
Participants either improved or maintained motor gains through one year
CT Appears to Be the Best First Strategy for Evaluating Stable Chest Pain
Authors say benefits include lower risk and cost, plus information on extent of coronary atherosclerosis
Pembrolizumab Shows Survival Benefit for Patients With Renal Cancer
Significant improvement seen in overall survival with pembrolizumab versus placebo and across key subgroups
Addition of Durvalumab, Bevacizumab to TACE Beneficial in Liver Cancer
Progression-free survival significantly improved in unresectable hepatocellular carcinoma versus TACE alone
